Cargando…

Serum Concentrations of Fibroblast Growth Factors 19 and 21 in Women with Gestational Diabetes Mellitus: Association with Insulin Resistance, Adiponectin, and Polycystic Ovary Syndrome History

BACKGROUND: Fibroblast growth factor 19 (FGF19) and FGF21 are considered to be novel adipokines that improve glucose tolerance and insulin sensitivity. In the current study, we investigated serum FGF19 and FGF21 levels in patients with gestational diabetes mellitus (GDM) and explored their relations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dongyu, Zhu, Wenjing, Li, Jieming, An, Chongyou, Wang, Zilian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834317/ https://www.ncbi.nlm.nih.gov/pubmed/24260557 http://dx.doi.org/10.1371/journal.pone.0081190

Ejemplares similares

Decreased placental and muscular expression of the fibroblast growth factor 19 in gestational diabetes mellitus
por: Wang, Dongyu, et al.
Publicado: (2018)

The relationship between total cholesterol and postpartum impaired glucose tolerance in women with gestational diabetes mellitus
por: Wang, Dongyu, et al.
Publicado: (2020)

Association between neonatal birthweight and risk of maternal glucose intolerance after gestational diabetes mellitus
por: Li, Zhuyu, et al.
Publicado: (2020)

Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011)

Longitudinal trends in lipid profiles during pregnancy: Association with gestational diabetes mellitus and longitudinal trends in insulin indices
por: Shen, Lixia, et al.
Publicado: (2023)

Serum adiponectin in Indian women with polycystic ovary syndrome
por: Rajendra, Aishwarya, et al.
Publicado: (2023)

Risks for Gestational Diabetes Mellitus and Pregnancy-Induced Hypertension Are Increased in Polycystic Ovary Syndrome
por: Wang, Yunhui, et al.
Publicado: (2013)

Adiponectin/(FBG × FIns) as a predictor of insulin sensitivity and metabolic syndrome in patients with polycystic ovary syndrome
por: Xu, Xiaohui, et al.
Publicado: (2016)

Role of osteocalcin, tumor necrosis factor-alpha and adiponectin in polycystic ovary syndrome patients with insulin resistance
por: Erkan, Gönül, et al.
Publicado: (2017)

The role of circular RNA circ_0008285 in gestational diabetes mellitus by regulating the biological functions of trophoblasts
por: Chen, Haitian, et al.
Publicado: (2021)

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Incidence Rate of Type 2 Diabetes Mellitus after Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of 170,139 Women
por: Li, Zhuyu, et al.
Publicado: (2020)

Serum Anti-Müllerian Hormone in Polycystic Ovary Syndrome and its Relationship with Insulin Resistance, Lipid Profile and Adiponectin
por: Jun, Thien Jun, et al.
Publicado: (2020)

Ovarian HMW adiponectin is associated with folliculogenesis in women with polycystic ovary syndrome
por: Tao, Tao, et al.
Publicado: (2013)

Association of adiponectin levels with polycystic ovary syndrome among Indian women
por: Patil, Sudha, et al.
Publicado: (2022)

Increased risk markers in women with polycystic ovary syndrome and gestational diabetes mellitus during mid-pregnancy
por: Zhang, Liqin, et al.
Publicado: (2020)

Adiponectin levels and its relation with insulin secretion and insulin sensitivity in a group of sub-Saharan African women with polycystic ovary syndrome
por: Momo, Audrey Synthia, et al.
Publicado: (2022)

Diagnostic Value of Bile Acids and Fibroblast Growth Factor 21 in Women with Polycystic Ovary Syndrome
por: Yoost, Jennie L., et al.
Publicado: (2022)

HbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome
por: Odsæter, Ingrid Hov, et al.
Publicado: (2015)

The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus
por: Rojas, Joselyn, et al.
Publicado: (2014)

Risk for Gestational Diabetes Mellitus and Adverse Birth Outcomes in Chinese Women with Polycystic Ovary Syndrome
por: Xiao, Qing, et al.
Publicado: (2016)

Serum adiponectin levels in gestational diabetes mellitus
por: Bhograj, Abhijit, et al.
Publicado: (2016)

Changes of Serum Adiponectin and Glycated Albumin Levels in Gestational Diabetes Mellitus Patients and Their Relationship with Insulin Resistance
por: WANG, Qingju, et al.
Publicado: (2020)

Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome
por: Li, Li, et al.
Publicado: (2020)

Polycystic ovary syndrome and risk factors for gestational diabetes
por: Mustaniemi, Sanna, et al.
Publicado: (2018)

Fibroblast Growth Factor 21 in Gestational Diabetes Mellitus and Type 2 Diabetes Mellitus
por: Gawlik, Katarzyna, et al.
Publicado: (2023)

Higher Peripheral Cholesterol and a Positive Correlation With Risk for Large-For-Gestational-Age Neonates in Pre-Pregnancy Underweight Women
por: Wang, Dongyu, et al.
Publicado: (2021)

Risk of Type 2 Diabetes Mellitus following Gestational Diabetes Pregnancy in Women with Polycystic Ovary Syndrome
por: Lo, Joan C., et al.
Publicado: (2017)

The risk factors of gestational diabetes mellitus in patients with polycystic ovary syndrome: What should we care
por: Li, Xiaocui, et al.
Publicado: (2021)

Risk prediction of gestational diabetes mellitus in women with polycystic ovary syndrome based on a nomogram model
por: Ouyang, Peilin, et al.
Publicado: (2023)

Adiponectin and Its Receptors in the Ovary: Further Evidence for a Link between Obesity and Hyperandrogenism in Polycystic Ovary Syndrome
por: Comim, Fabio V., et al.
Publicado: (2013)

Insulin resistance and fertility in polycystic ovary syndrome.
por: Fica, S, et al.
Publicado: (2008)

Association between lipid trajectories during pregnancy and risk of postpartum glucose intolerance after gestational diabetes mellitus: a cohort study
por: Yang, Zhuofan, et al.
Publicado: (2022)

Serum Adiponectin Level and Clinical, Metabolic, and Hormonal Markers in Patients with Polycystic Ovary Syndrome
por: Yildiz, Yunus, et al.
Publicado: (2014)

The incidence of gestational diabetes mellitus among women with polycystic ovary syndrome: a meta-analysis of longitudinal studies
por: Yan, Qingzi, et al.
Publicado: (2022)

Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome
por: Hamilton, Kristen P, et al.
Publicado: (2019)

Hepcidin levels in diabetes mellitus and polycystic ovary syndrome
por: Sam, A H, et al.
Publicado: (2013)

Effect of Vitamin D(3) on Chemerin and Adiponectin Levels in Uterus of Polycystic Ovary Syndrome Rats
por: Pich, Karolina, et al.
Publicado: (2023)

New markers of insulin resistance in polycystic ovary syndrome
por: Polak, K., et al.
Publicado: (2016)

Limitations of insulin resistance assessment in polycystic ovary syndrome
por: Lewandowski, Krzysztof C, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_290ajnauvm4bksdvgjktk5es07